Summary & Overview
HCPCS C9059: Injection, Meloxicam, 1 mg
HCPCS Level II code C9059 denotes an injection of meloxicam, 1 mg, used for parenteral management of pain and inflammation. Nationally, this injectable formulation matters for outpatient procedural billing, pharmacy-administration workflows, and payer coverage policies for NSAID injections. Accurate coding supports claim adjudication, inventory tracking, and clinical documentation when meloxicam is administered by clinicians.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of where this service is typically provided, common billing considerations, and what payers commonly evaluate for injectable medication claims. The publication covers benchmark contexts, clinical use considerations for an injectable NSAID, and how coverage policies and reimbursement practices can affect site-of-service decisions.
This summary equips clinical coders, billing managers, and policy analysts with the essential context for HCPCS Level II code C9059, clarifying its clinical purpose and relevance to outpatient billing and payer interactions. Data not available in the input is noted where applicable in detailed sections.
Billing Code Overview
HCPCS Level II code C9059 describes an injection of meloxicam, 1 mg. This code represents a single-dose parenteral administration of meloxicam, a nonsteroidal anti-inflammatory drug (NSAID) used to manage pain and inflammation.
-
Service type: Medication injection
-
Typical site of service: Outpatient clinic, physician office, ambulatory surgery center, or other outpatient infusion/injection settings
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with chronic osteoarthritis of the knee presents for an in-clinic intra-articular analgesic injection when oral nonsteroidal anti-inflammatory drugs are contraindicated due to gastrointestinal bleeding risk and chronic kidney disease. The clinician prepares a single-dose syringe of meloxicam injectable formulation billed as C9059 (Injection, meloxicam, 1 mg). The care team verifies allergies and medication reconciliation, obtains informed consent for an off‑label or alternative analgesic injection if applicable, and performs aseptic skin preparation at the outpatient clinic or ambulatory infusion area. The clinician administers the injection into the affected joint using sterile technique, monitors the patient for immediate adverse reactions for 15–30 minutes, documents medication lot number, dose, route, site, and patient response in the medical record, and schedules follow-up for efficacy and safety assessment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the service required substantially greater effort or complexity than typical for a medication injection, with supporting documentation. |
23 |